Biesterfeld create new business unit pharmaceutical activities

Biesterfeld to create new business unit for pharmaceutical activities

11:51 AM, 23rd October 2017
Biesterfeld logo

HAMBURG, GERMANY: Biesterfeld Spezialchemie GmbH said that as part of its ongoing drive to develop market segment focus it is creating a new business unit for healthcare distribution. This move is a logical continuation of previous developments and will allow the distributor to effectively target this highly demanding market, the company said.

The new business unit will combine the pharmaceutical activities of Schutz & Co, acquired in 2016, and the business of the current pharmaceutical and medical devices segments. The unit will be headed by Andreas Lekebusch, who has a PhD in chemistry and has significantly shaped the strategic alignment and operational implementation of pharmaceutical and medical devices activities at Biesterfeld Spezialchemie for almost 20 years.

Biesterfeld collaborates with leading manufacturers in its extensive healthcare product portfolio. In addition to elastomers and adhesives for the manufacturing of medical devices, the distributor supplies high-purity silicones for coating syringes and cannulas. A wide range of pharmaceutical active ingredients from qualified partners and excipients for solid, liquid and topical products enables Biesterfeld to supply high-quality raw materials to the pharmaceutical industry.

The product and service portfolio will be developed and expanded in line with a targeted strategy. The development of target markets in Europe, the Middle East and Russia will continue to have high priority.

"The healthcare market is influenced by megatrends that will have a crucial impact on society, which makes it an attractive growth market for us. We understand the exceptionally stringent requirements in this segment and we have aligned our distribution business accordingly. Setting up this business unit is an important step in our strategy of delivering competent, intensive and highly focused service to very demanding market segments," said Peter Wilkes, managing director of Biesterfeld Spezialchemie.

"The distribution of products to the pharmaceutical industry and medical device manufacturers is complex and demanding. With our extensive market knowledge and technical know-how, we are able to provide competent, tailored customer service, which is why we are regarded as experts in the market. We give high priority to quality management and taking responsibility for quality, which is especially important in the distribution of pharmaceutical active ingredients," added Andreas Lekebusch, business manager healthcare at Biesterfeld Spezialchemie.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Fluor bags JG Summit’s petrochemical complex expansion contract

IRVING, US: Fluor Corporation (FLR) has been awarded an engineering, procurement and construction management (EPCM) contract for the utilities, o ...

Read more
Ascend launches new polyamide 66 for electrical components

HOUSTON, US: Ascend Performance Materials LLC has launched Vydyne FR350J, a new high-performance compound based on polyamide 66 (PA66) that will bring ...

Read more
Sabo to increase hindered amine light stabilizers capacity

BERGAMO, ITALY: Sabo SpA, is implementing a major capacity expansion for hindered amine light stabilizers SABO STAB UV 70 and SABO STAB UV 91, and rel ...

Read more
ExxonMobil expands Clinton research centre to include engine testing plant

CLINTON, US: ExxonMobil Corporation has broken ground on the expansion of its research facility in Clinton, New Jersey, a key centre of innovation tha ...

Read more
AkzoNobel plans chloromethanes capacity expansion in Germany

AMSTERDAM, NETHERLANDS: AkzoNobel NV has entered the design phase for a further chloromethanes capacity expansion in Germany. Chloromethanes are a key ...

Read more
Lanxess adds new closed-circuit RO module to its LewaPlus software

COLOGNE, GERMANY: Lanxess AG has announced a new addition to its LewaPlus software suite of reverse osmosis (RO) and ion exchange (IX) system dimensio ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X